The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.
Cerebroprotection after administration of glutamate receptor antagonists has been well documented. The present study is intended to determine whether the non-competitive alpha-amino-3-hydroxy-methyl-4-isoxazolyl-propionic acid (AMPA) receptor antagonist talampanel, known as antiepileptic drug, has n...
| Main Authors: |
Erdő Franciska Berzsenyi P Andrasi F |
|---|---|
| Format: | Article |
| Published: |
2005
|
| Series: | BRAIN RESEARCH BULLETIN
66 No. 1 |
| Subjects: | |
| doi: | 10.1016/j.brainresbull.2005.03.012 |
| mtmt: | 2802858 |
| Online Access: | https://publikacio.ppke.hu/2378 |
Similar Items
-
Talampanel improves the functional deficit after transient focal cerebral ischemia in rats. A 30-day follow up study.
by: Erdő Franciska, et al.
Published: (2006) -
Immunohistochemical analysis of protein expression after middle cerebral artery occlusion in mice.
by: Erdő Franciska, et al.
Published: (2004) -
Endocannabinoids in the development of the cerebral cortex, and their metabolic enzymes
by: Nagy Dániel
Published: (2022) -
Machine learning principles in the neural mechanisms of the cerebral cortex
by: Kertész Borbála
Published: (2021) -
Pathomechanism of intestinal ischemia/reperfusion injury and its potential therapeutic targets
by: Hegyes Tamás
Published: (2014)